Behind Generate's 'feverish' race to raise $400M IPO while window remains open - Fierce Biotech

By Anonymous User · February 28, 2026

Behind Generate's 'feverish' race to raise $400M IPO while window remains open  Fierce BiotechGenerate Biomedicines shares fall in weak Nasdaq debut for drug developer  ReutersGenerate caps a strong month for biotech IPOs with $400M offering  BioPharma DiveFlagship-Backed Generate Biomedicines Raises $400 Million in IPO  Yahoo FinanceGenerate:Biomedicines Rings the Opening Bell  Nasdaq